As senior director, Patricia provides product development and global strategic regulatory advice to external and internal clients, determining the most appropriate strategy for their projects. Since joining PPD in 2010 as a manager in global regulatory development, she has successfully supported many clients with global clinical trial authorization applications and strategic consulting discussions in several disease areas. Patricia is based in the PPD Cambridge office in the UK, is a leading member of PPD’s advanced therapies forum, and is a member of PPD’s biosimilar development group. In addition, she belongs to The Organization for Professionals in Regulatory Affairs (TOPRA) and sits on the editorial board of Regulatory Rapporteur.
Prior to joining PPD, Patricia was head of project management and biomarkers division at a London-based regulatory and product development consulting group where she undertook the full range of global regulatory activities.
Patricia has a doctorate in molecular pharmacology and a bachelor’s in pharmacology and molecular genetics from University College in Dublin, Ireland.